A Case of Hepatocellular Carcinoma with Pulmonary Metastases Treated Successfully with a Combination of Repeated Hepatic Arterial Infusion Epirubicin and Cisplatin Chemotherapy and Systemic Low-Dose Infusion of 5-Fluorouracil
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report a case of hepatocellular carcinoma (HCC) with pulmonary metastases treated with repeated hepatic arterial infusion chemotherapy (HAIC) comprising epirubicin and cisplatin, and systemic infusion of 5-fluorouracil (a modified EC/F protocol), which led to complete remission. A 49-year-old man with compensated liver cirrhosis experienced intrahepatic recurrence of HCC with extensive lung metastases. The modified EC/F therapeutic protocol, which was applied at the tenth cycle every 4-5 weeks, resulted in disappearance of the pulmonary metastases and normalization of serum α-fetoprotein levels. A single small HCC lesion was found in the left lobe of the liver 13 months after the final chemotherapy session. HAIC with the same regimen was conducted again, followed by percutaneous intratumoral chemoinjection therapy with 5-fluorouracil and interferon-γ. Thereafter, there was no evidence of recurrence in either the liver or the lung, as evidenced by image analysis and expression of tumor markers. The disease-free intervals for the liver and lung were 41 and 54 months, respectively.
Abstract
We report a case of hepatocellular carcinoma (HCC) with pulmonary metastases treated with repeated hepatic arterial infusion chemotherapy (HAIC) comprising epirubicin and cisplatin, and systemic infusion of 5-fluorouracil (a modified EC/F protocol), which led to complete remission. A 49-year-old man with compensated liver cirrhosis experienced intrahepatic recurrence of HCC with extensive lung metastases. The modified EC/F therapeutic protocol, which was applied at the tenth cycle every 4-5 weeks, resulted in disappearance of the pulmonary metastases and normalization of serum α-fetoprotein levels. A single small HCC lesion was found in the left lobe of the liver 13 months after the final chemotherapy session. HAIC with the same regimen was conducted again, followed by percutaneous intratumoral chemoinjection therapy with 5-fluorouracil and interferon-γ. Thereafter, there was no evidence of recurrence in either the liver or the lung, as evidenced by image analysis and expression of tumor markers. The disease-free intervals for the liver and lung were 41 and 54 months, respectively.
참고문헌 (22)
- Korea National Statistical Office, "Annual report on the cause of death statistics, 2005" (2006), Korea National Statistical Office
- Bruix J, "Prognostic prediction and treatment strategy in hepatocellular carcinoma", Hepatology, 35, pp.519~524 (2002)
- Katyal S, "Extrahepatic metastases of hepatocellular carcinoma", Radiology, 216, pp.698~703 (2000)
- Park JW, "Epidemiology of hepatocellular carcinoma in Korea", Korean J Hepatol, 11, pp.303~310 (2005)
- Lam CM, "Prolonged survival in selected patients following surgical resection for pulmonary metastasis form hepatocellular carcinoma", Br J Surg, 85, pp.1198~1200 (1998)
- Maeda T, "Low-dose cisplatin plus oral tegafur and uracil for the treatment of lung metastases of hepatocellular carcinoma", Hepatogastoenterology, 50, pp.1583~1586 (2003)
- Enoki T, "A case of multiple lung metastases of hepatocellular carcinoma after resection of liver and tumor thrombi in the inferior vena cava responding to chemotherapy using 5-FU, mitoxantrone and CDDP", Gan To Kagaku Ryoho, 34, pp.229~231 (2007)
- Jang JW, "Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma", Cancer Chemother Pharmacol, 54, pp.415~420 (2004)
- Falkson G, "Primary liver cancer: an Eastern Cooperative Oncology Group Trial", Cancer, 54, pp.970~977 (1984)
- Falkson G, "A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: an ECOG study", Cancer, 60, pp.2141~2145 (1987)
- Ganne-Carrié N, "Systemic treatment of hepatocellular carcinoma", Eur J Gastroenterol Hepatol, 16, pp.275~281 (2004)
- Haskell CM, "Cancer treatment. 5th ed", pp.2038~2039 (2001), WB Saunders
- Tzoracoleftherakis EE, "Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma", Hepatogastroenterology, 46, pp.1122~1125 (1999)
- Kajanti M, "Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma: a phase II study", Cancer, 58, pp.2386~2388 (1986)
- Kalayci C, "Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin", J Hepatol, 11, pp.349~353 (1990)
- Toyoda H, "The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma", Oncology, 52, pp.295~299 (1995)
- Ando E, "A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein", Cancer, 79, pp.1890~1896 (1997)
- Kogure T, "Complete remission of a case of hepatocellular carcinoma with tumor invasion in inferior vena cava and with pulmonary metastasis successfully treated with repeated arterial infusion chemotherapy", Hepatogastroenterology, 54, pp.2113~2116 (2007)
- Shirasaka T, "Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo", Cancer Chemother Pharmacol, 32, pp.167~172 (1993)
- Iida T, "Complete response to treatment with hepatic arterial infusion of cisplatin powder (IA-call) in a case of hepatocellular carcinoma with multiple lung metastases", Nippon Shokakibyo Gakkai Zasshi, 104, pp.1738~1744 (2007)
- Anami Y, "Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil", cisplatin therapy, 2005, pp.32, 1977~1980
- Fukuda Y, "Complete response to treatment with low-dose FP therapy in a patient withstage IVB primary hepatocellular carcinoma with multiple lung and bone metastases", Gan To Kagaku Ryoho, 31, pp.107~111 (2004)